Efficacy Evaluation of Enobosarm Monotherapy in Treatment of AR+/ER+/HER2- Metastatic Breast Cancer

NCT04869943 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

52

Enrollment

INDUSTRY

Sponsor class

Stopped Business decision

Conditions

Metastatic Breast Cancer

Interventions

DRUG: Enobosarm
DRUG: Exemestane

Sponsor

Veru Inc.